数学
样本量测定
统计
随机对照试验
估计员
对数秩检验
随机化
阶段(地层学)
结果(博弈论)
随机试验
计量经济学
生存分析
医学
外科
数理经济学
古生物学
生物
出处
期刊:Biometrika
[Oxford University Press]
日期:2011-07-13
卷期号:98 (3): 503-518
被引量:37
标识
DOI:10.1093/biomet/asr019
摘要
Two-stage randomized trials are growing in importance in developing adaptive treatment strategies, i.e. treatment policies or dynamic treatment regimes. Usually, the first stage involves randomization to one of the several initial treatments. The second stage of treatment begins when an early nonresponse criterion or response criterion is met. In the second-stage, nonresponding subjects are re-randomized among second-stage treatments. Sample size calculations for planning these two-stage randomized trials with failure time outcomes are challenging because the variances of common test statistics depend in a complex manner on the joint distribution of time to the early nonresponse criterion or response criterion and the primary failure time outcome. We produce simple, albeit conservative, sample size formulae by using upper bounds on the variances. The resulting formulae only require the working assumptions needed to size a standard single-stage randomized trial and, in common settings, are only mildly conservative. These sample size formulae are based on either a weighted Kaplan-Meier estimator of survival probabilities at a fixed time-point or a weighted version of the log-rank test.
科研通智能强力驱动
Strongly Powered by AbleSci AI